{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T06:34:34Z","timestamp":1774852474114,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12185-020-02847-4","type":"journal-article","created":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T13:03:06Z","timestamp":1583931786000},"page":"771-778","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prediction of response to first-line therapy with ITP by flow cytometric analysis of bone marrow lymphocyte phenotypes"],"prefix":"10.1007","volume":"111","author":[{"given":"Satoko","family":"Oka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Nohgawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,11]]},"reference":[{"key":"2847_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2141.2006.06024.x","volume":"133","author":"N Cooper","year":"2006","unstructured":"Cooper N, Bussel J. The pathogenesis of immune thrombocytopaenic purpura. Br J Haematol. 2006;133:364\u201374.","journal-title":"Br J Haematol"},{"key":"2847_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12185-017-2264-7","volume":"106","author":"M Matsumoto","year":"2017","unstructured":"Matsumoto M, Fujimura Y, Wada H, Kokame K, Miyakawa Y, Ueda Y, et al. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan. Int J Hematol. 2017;106:3\u201315.","journal-title":"Int J Hematol"},{"key":"2847_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12185-019-02790-z","volume":"111","author":"H Kashiwagi","year":"2020","unstructured":"Kashiwagi H, Kuwana M, Hato T, Takafuta T, Fujimura K, Kurata Y, et al. Reference guide for management of adult immune thrombocytopenia in Japan: 2019 Revision. Int J Hematol. 2020;111:329\u201351.","journal-title":"Int J Hematol"},{"key":"2847_CR4","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0002-9343(99)80342-8","volume":"98","author":"R Stasi","year":"1995","unstructured":"Stasi R, Stipa E, Masi M, Cecconi M, Scim\u00f2 MT, Oliva F, et al. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med. 1995;98:436\u201342.","journal-title":"Am J Med"},{"key":"2847_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","volume":"115","author":"D Provan","year":"2010","unstructured":"Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168\u201386.","journal-title":"Blood"},{"key":"2847_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1756-8722-6-28","volume":"6","author":"AM Rocha","year":"2013","unstructured":"Rocha AM, Souza C, Rocha GA, de Melo FF, Clementino NC, Marino MC, et al. The serum levels of the cytokines involved in the Th17 and Th1 cell commitment are increased in individuals with borderline thrombocytopenia. J Hematol Oncol. 2013;6:28.","journal-title":"J Hematol Oncol"},{"key":"2847_CR7","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1182\/blood-2008-01-135335","volume":"112","author":"J Yu","year":"2008","unstructured":"Yu J, Heck S, Patel V, Levan J, Yu Y, Bussel JB, Yazdanbakhsh K. Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura. Blood. 2008;112:1325\u20138.","journal-title":"Blood"},{"key":"2847_CR8","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1182\/blood-2009-09-244772","volume":"115","author":"L Chow","year":"2010","unstructured":"Chow L, Aslam R, Speck ER, Kim M, Cridland N, Webster ML, et al. A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy. Blood. 2010;115:1247\u201353.","journal-title":"Blood"},{"key":"2847_CR9","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s12185-017-2392-0","volume":"107","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Ma T, Zhou X, Chen J, Li J. Circulating level of Th17 cells is associated with sensitivity to glucocorticoids in patients with immune thrombocytopenia. Int J Hematol. 2018;107:442\u201350.","journal-title":"Int J Hematol"},{"key":"2847_CR10","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386\u201393.","journal-title":"Blood"},{"key":"2847_CR11","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","volume":"117","author":"C Neunert","year":"2011","unstructured":"Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190\u2013207.","journal-title":"Blood"},{"key":"2847_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/ajh.2830370409","volume":"37","author":"JW Semple","year":"1991","unstructured":"Semple JW, Bruce S, Freedman J. Suppressed natural killer cell activity in patients with chronic autoimmune thrombocytopenic purpura. Am J Hematol. 1991;37:258\u201362.","journal-title":"Am J Hematol"},{"key":"2847_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/cei.12279","volume":"176","author":"RM Talaat","year":"2014","unstructured":"Talaat RM, Elmaghraby AM, Barakat SS, El-Shahat M. Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP). Clin Exp Immunol. 2014;176:291\u2013300.","journal-title":"Clin Exp Immunol"},{"key":"2847_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3892\/etm.2013.1386","volume":"7","author":"R Xu","year":"2014","unstructured":"Xu R, Zheng Z, Ma Y, Hu Y, Zhuang S, Wei B, et al. Elevated NKT cell levels in adults with severe chronic immune thrombocytopenia. Exp Ther Med. 2014;7:149\u201354.","journal-title":"Exp Ther Med"},{"key":"2847_CR15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.autrev.2010.11.009","volume":"10","author":"M Zen","year":"2011","unstructured":"Zen M, Canova M, Campana C, Bettio S, Nalotto L, Rampudda M, et al. The kaleidoscope of glucorticoid effects on immune system. Autoimmun Rev. 2011;10:305\u201310.","journal-title":"Autoimmun Rev"},{"key":"2847_CR16","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1056\/NEJM198205273062102","volume":"306","author":"J Fehr","year":"1982","unstructured":"Fehr J, Hofmann V, Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med. 1982;306:1254\u20138.","journal-title":"N Engl J Med"},{"key":"2847_CR17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1182\/blood-2007-03-079947","volume":"111","author":"A Ephrem","year":"2008","unstructured":"Ephrem A, Chamat S, Miquel C, Fisson S, Mouthon L, Caligiuri G, et al. Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis. Blood. 2008;111:715\u201322.","journal-title":"Blood"},{"key":"2847_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12185-010-0753-z","volume":"93","author":"Z Li","year":"2011","unstructured":"Li Z, Mou W, Lu G, Cao J, He X, Pan X, et al. Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia. Int J Hematol. 2011;93:91\u20138.","journal-title":"Int J Hematol"},{"key":"2847_CR19","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1182\/blood-2010-04-281717","volume":"116","author":"W Bao","year":"2010","unstructured":"Bao W, Bussel JB, Heck S, He W, Karpoff M, Boulad N, et al. Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents. Blood. 2010;116:4639\u201345.","journal-title":"Blood"},{"key":"2847_CR20","doi-asserted-by":"publisher","first-page":"e0126601","DOI":"10.1371\/journal.pone.0126601","volume":"10","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Yang L, Yang G, Zhuang Y, Qian X, Zhou X, et al. Contributions of T lymphocyte abnormalities to therapeutic outcomes in newly diagnosed patients with immune thrombocytopenia. PLoS ONE. 2015;10:e0126601.","journal-title":"PLoS ONE"},{"key":"2847_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1182\/blood-2015-03-635417","volume":"126","author":"L Ma","year":"2015","unstructured":"Ma L, Simpson E, Li J, Xuan M, Xu M, Baker L, et al. CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia. Blood. 2015;126:247\u201356.","journal-title":"Blood"},{"key":"2847_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/ar1034","volume":"6","author":"AR French","year":"2004","unstructured":"French AR, Yokoyama WM. Natural killer cells and autoimmunity. Arthritis Res Ther. 2004;6:8\u201314.","journal-title":"Arthritis Res Ther"},{"key":"2847_CR23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1365-2141.2004.04896.x","volume":"125","author":"U Johansson","year":"2004","unstructured":"Johansson U, Macey MG, Kenny D, Provan D, Newland AC. Alpha-galactosylceramide-driven expansion of human natural killer T cells is inhibited by prednisolone treatment. Br J Haematol. 2004;125:400\u20134.","journal-title":"Br J Haematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-02847-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-020-02847-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-02847-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T01:06:15Z","timestamp":1615424775000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-020-02847-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,11]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["2847"],"URL":"https:\/\/doi.org\/10.1007\/s12185-020-02847-4","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,11]]},"assertion":[{"value":"7 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict interest"}}]}}